What Is GPS1 and the COP9 Signalosome?

GPS1 (G-protein suppressor 1), also designated CSN1 or COPS1, is the largest and defining subunit of the COP9 signalosome (CSN), an evolutionarily conserved multi-protein complex found in all eukaryotes. The CSN complex is structurally homologous to the 19S regulatory lid of the 26S proteasome and shares architectural similarities with the eIF3 translation initiation factor complex.

The COP9 signalosome consists of eight subunits (CSN1–CSN8). GPS1/CSN1 anchors the complex and contributes to its structural integrity. The complex was originally identified in plants as a repressor of photomorphogenesis, but has since been recognized as a master regulator of the ubiquitin-proteasome system across species, including humans.

GPS1 contains a PCI (Proteasome, COP9, eIF3) domain, which mediates protein–protein interactions within the CSN complex and with external binding partners, making it a critical scaffold for signaling events.

Biological Functions and Signaling Roles

The primary enzymatic activity attributed to the COP9 signalosome is the deneddylation of cullin proteins — the removal of the ubiquitin-like modifier NEDD8 from cullins, which are scaffold components of cullin-RING ubiquitin ligases (CRLs). This deneddylation is catalyzed by the metalloprotease activity residing in CSN5, but GPS1/CSN1 and other subunits are essential for full complex activity and substrate selectivity.

By controlling CRL activity, GPS1 and the CSN complex regulate the stability and turnover of numerous substrate proteins involved in:

• Cell cycle progression: degradation of cyclins and CDK inhibitors
• DNA damage response: regulation of p53 and other checkpoint proteins
• Transcription factor stability: controlling abundance of key transcriptional regulators
• Hormone and immune signaling: modulating receptor and adaptor protein levels

GPS1 has also been independently linked to the suppression of G-protein-mediated signaling pathways, consistent with its original nomenclature as a G-protein suppressor.

Research Applications of Recombinant Human GPS1 Protein

Recombinant Human GPS1 Protein produced under controlled manufacturing conditions provides researchers with a defined, reproducible reagent suitable for a range of biochemical and cell biology experiments:

• Protein–protein interaction studies: GPS1 can be used in co-immunoprecipitation, pull-down assays, or surface plasmon resonance (SPR) experiments to map interactions with other CSN subunits, cullin-RING ligase components, or novel binding partners.
• Enzyme activity assays: As part of reconstituted CSN complex studies, GPS1 contributes to understanding the stoichiometric requirements for deneddylase activity.
• Antibody validation and ELISA standards: Purified recombinant GPS1 serves as a positive control or standard for immunoassay development.
• Structural biology: High-purity recombinant protein is suitable for use in crystallography, cryo-EM, or biophysical characterization studies of CSN complex assembly.
• Drug discovery: GPS1 and the CSN complex are emerging therapeutic targets; recombinant GPS1 supports compound screening and mechanistic validation assays.

Handling, Storage, and Quality Considerations

When working with Recombinant Human GPS1 Protein, adherence to best practices for recombinant protein handling is essential to preserve activity and integrity:

• Storage: Store lyophilized or liquid protein preparations according to the product datasheet. In general, recombinant proteins should be stored at –20 °C or –80 °C to prevent degradation; avoid repeated freeze–thaw cycles by preparing single-use aliquots.
• Reconstitution: Reconstitute lyophilized protein in the recommended buffer (typically sterile PBS or carrier protein-containing buffer) as specified in the product documentation.
• Protein integrity verification: Confirm protein purity and molecular weight by SDS-PAGE prior to use. GPS1 has a predicted molecular weight consistent with its amino acid sequence; verify against datasheet specifications.
• Activity confirmation: Where activity is critical, include appropriate positive controls and validate protein function in a pilot experiment before committing to large-scale studies.
• Sterility: For cell-based assays, use sterile-filtered protein solutions and handle under aseptic conditions.

Refer to the product datasheet (absea #PP-414) for lot-specific quality control data including purity, endotoxin levels, and activity validation results.